Deutsche downgrades Merck ahead of Keytruda 2028 expiration
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the ...
Merck KGaA to replace two executives with company veterans
Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...
Merck downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a $105 price target Discover the Best Stocks and Maximize Your ...
Exclusive: Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial
Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus ...
Gilead upped on HIV franchise; Merck downgraded on Keytruda LoE at Deutsche Bank
Gilead (GILD) stock won an upgrade from Deutsche Bank on HIV treatment boost, while Merck (MRK) stock received a downgrade on ...
Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight
DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...
DelveInsight Business Research, LLP: Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...
Investing21h
US Dollar Index (DXY)
Stay ahead of the latest tech trends with our algorithmically-selected portfolio of the 15 top tech stocks each month.
The New York Times21h
New York Times - Top Stories
4 Top Officials Say They Will Resign Over Adams’s Cooperation With Trump Four deputy mayors to Mayor Eric Adams of New York are leaving after Mr. Adams embraced President Trump’s immigration ...